# Bio ReFine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bio-refine

- Industry: Medical Devices & Equipment
- Headquarters: Israel
- Latest round: Seed (Oct 1, 2025)
- Investors on record: 1

## About

Based in Israel, Bio ReFine Ltd. operates as a developer of an endovascular annuloplasty remodeling system. The company was founded by its CEO, Boaz Shenhav. Bio ReFine Ltd. raised venture funding from Peregrine Ventures.

Bio ReFine offers medical devices focused on interventional structural cardiology. The firm’s devices address mitral and tricuspid valve regurgitation, a heart condition affecting millions. The company provides a novel implant-less annuloplasty repair technique performed through a catheter for repairing mitral and tricuspid heart valves. The firm utilizes a catheter-based, endovascular procedure to remodel the valve annulus without implanting any foreign material.

## Funding rounds

- Seed, Oct 1, 2025 — Peregrine Ventures
- Seed, Feb 1, 2023 — Peregrine Ventures

## Investors

- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Seed